📰 Genentech News
Page 158 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
May 18, 2023
A company focusing on developing fibrin-targeted therapies to treat inflammatory neurodegenerative and retinal diseases announced the initiation of dosing for its lead asset THN391Monday (May 15) .
May 18, 2023
The current understanding of long COVID’s pathogenesis may be better served by looking to other diseases and syndromes, particularly fibromyalgia, according to a speaker at the 2023 Biologic Therapies Summit.
May 17, 2023
–– Fenebrutinib is an investigational, potent and highly selective oral Bruton’s tyrosine kinase inhibitor, the only reversible BTK inhibitor currently in Phase III multiple... | May 17, 2023
May 17, 2023
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will be showcasing innovative laboratory solutions and digital diagnostics through -...
May 17, 2023
Fenebrutinib is an investigational, potent and highly selective oral Bruton's tyrosine kinase (BTK) inhibitor, the only reversible BTK inhibitor currently in Phase III multiple sclerosis (MS) trialsPhase
May 17, 2023
Fenebrutinib is an investigational, potent and highly selective oral Bruton’s tyrosine kinase inhibitor, the only reversible BTK inhibitor currently in Phase III multiple sclerosis trialsPhase... | May 17, 2023
May 17, 2023
Roche will unveil the next generation of its serum work area, several molecular systems and the cobas® connection module. The company will introduce navify® digital solutions that help laboratories
May 17, 2023
SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, affiliated to Swiss drug major Roche Group (RHHBY), announced Wednesday positive results from the Phase II FENopta study evaluating investigational oral
May 17, 2023
Jack O’Brien interviews Quita Highsmith, Genentech's chief diversity officer, about findings from the biotech’s third annual D&I report. Lecia Bushak explains why the DEA is extending pandemic-era telehealth flexibility for accessing controlled substances.
May 17, 2023
/PRNewswire/ -- AllianceRx Walgreens Pharmacy, one of the largest specialty and home delivery pharmacies in the U.S., will now distribute two medications...